Unknown gram positive: Bacillus subtilis Unknown gram negative: Enterobacter aerogenes
I.
6. A Voges-Proskauer test was conducted by inoculating the media with the unknown and incubated 37F for twenty-four hours. The test was to detect the production of acetoin and to differentiate between B. megaterium, B. stearothermophilus, B. sphaericus and B. subtilis.
Day 4 July 29, 2009 1. The Simmon Citrate test indicated the bacterium was capable of producing citrase. Citrase production indicates that the unknown could not be B. stearothermophilus. 2. After the Voges-Proskauer media was incubated with the microbe at 37F for twenty-four hours, Voges-Proskauer reagent A and reagent B were added to the mixture. Though the mixture appeared green at first, after a period of approximately ten minutes, the mixture turned red which indicated a positive reading for acetoin. This test eliminated the possibility the unknown could be B. megaterium or B. sphaericus, which only left B. subtilis. 3. A glucose test was done to confirm B. subtilis. The glucose test was incubated over night for 37F. Day 5 July 30, 2009 1. Results for the glucose were read. The test result showed that the bacteria could ferment glucose and produce acid, but not gas. This coincides with the capabilities of Bacillus subtilis.
B.
C.
Gram Positive
Bacillus
Cocci
Non-Spore forming
Spore forming
Anaerobe
Aerobe
Glucose fermenter
Glucose non-fermenter
Citrase Positive
Citrase Negative
VP Positive
VP Negative
D.
HABITAT
Bacillus subtilis is an obligate aerobe and a ubiquitous organism commonly found in water, soil, air and decomposing plant residue (Bacillus subtilis Final Risk Assessment [updated 2007]). Because of its ubiquity, the organism is capable of growing in a wide range of temperatures. It may also be capable of growing on the human body, however lacks mechanism for attachments, therefore might only be transient inhabitants of the body. In the soil or water, it must compete with other microbes and is also exposed to variations in temperature, humidity and nutrient concentrations. To overcome its adversities, B. subtilis must have mechanisms to not only protect itself and find nutrients, but also fend off competitors.
E.
CLINICAL SIGNFICANCE
Bacillus subtilis is not known to be pathogenic to humans, though some studies have shown that they are capable of producing toxins that may be responsible for food poisoning. B. subtilis is considered to have low virulence to humans (Bacillus subtilis Final Risk Assessment [updated 2007]). However, because their natural habitat is in areas where competing bacteria, fungus and other microorganisms exist, they are capable of producing insect toxins, peptide antibiotics, and antifungals (Bacteria Genomes Bacillus subtilis [updated 2009]). B. subtilis is capable of producing over two dozen antibiotics including bacitracin, a topical antibiotic used to prevent infections (Stein 2005). It is one of the most widely used bacteria for the production of enzymes. It also has industrial applications which allow for the production of amylase, protease, inosine, ribosides and amino acids. The ability of B. subtilis to produce antifungals have also lend to the production of fungicides and treatment for agricultural crop protection.
F.
SPECIAL CHARACTERISITCS
Bacillus subtilis was the first Gram positive bacteria to be sequenced. The endospore staining test showed that B. subtilis is capable of producing endospores, which would allow it to survive harsh times with limited nutrients and aversive environmental conditions. The endospore can withstand extreme conditions of high heat, acidity and salinity. During these times, however, the organism is not biologically active (Bacillus subtilis Final Risk Assessment [updated 2007]). The result of the motility test showed that the organism was motile. Research from literature confirms that B. subtilis is capable of movement by peritrichous flagella (Bacillus subtilis Final Risk Assessment [updated 2007]). When it is active, B. subtilis utilizes chemotaxis and uses its flagella to move towards nutrients, as well as away from toxins from competing microorganisms (Sonenshein 2002). B. subtilis is also capable of producing a variety of enzymes to both cycle nutrients and ward of offensive organisms as mentioned above.
Day 4 July 29, 2009 1. The lactose test indicated the organism was capable of fermenting lactose to produce acid and gas. The ability to ferment lactose indicates that the organism could not be Proteus, Pseudomonas, Salmonella, Acaligenes faecalis, Morganella or Serratia marcescens. 2. The Glucose test indicated the organisms were capable of fermenting glucose and producing acid and gas. The glucose test did not further eliminate any species that had not already been eliminated by the lactose test and the motility test. 3. The SIM test indicated that the organism did not produce indole. The test eliminated the possibility that the organism could be Escherichia coli and Citrobacter diversus. 4. The SIM test also tested for hydrogen sulfide production, which also had negative results. The negative result eliminated the possibility that the organism could be Citrobacter freundii. This test left only the possibility that the organism was of the genus Enterobacter. The only test differentiate between Enterobacter cloacae and Enterobacter aerogenes is a lysine test, which tests for the decarboxylation of lysine into an alkaline end product. 5. A lysine test was done to differentiate between Enterobacter cloacae and Enterobacter aerogenes. The test was incubated at 37F. Day 5 July 30, 2009 1. After twenty-four hours, the test results were not clear because the solution looked only opaque rather than a definitive purple for a positive result or a yellow for a negative result. The media was allowed to incubate for a total of four days. Day 6 August 3, 2009 1. The results of the lysine test were vague, however with the assistance of the lab professor, it was interpreted to have a slight purple hue indicating that the test was positive, which would indicate that the unknown organism was Enterobacter aerogenes.
C.
Gram Negative
Cocci
Bacillus
Motile
Non-motile
Lactose non-fermenting
Lactose fermenting
Indole positive
Indole negative
H2S positive
H2S negative
Lysine positive
Lysine negative
D. HABITAT
Enterobacter aerogenes is a facultative anaerobe with an optimum temperature of around 37F. It is part of the normal flora of the human and animal intestines, and can be found in feces. It has also been isolated from soil, water, sewage, some dairy products and hospitals (Microbial Glossary).
E. CLINICAL SIGNIFICANCE
Though Enterobacter aerogenes is part of the normal flora of humans, they can also be opportunistic pathogens, especially common as a nosocomial pathogen. E. aerogenes can cause several infections including bacteremia, lower respiratory tract infection, skin and soft-tissue infections, urinary tract infections, endocarditis, intra-abdominal infections, septic arthritis, osteomyelitis, and ophthalmic infections (Enterobacter Infections 2008). Nosocomial infections of E. aerogenes is the most common form of infection. Infection is rare amongst healthy individuals. Sources of infection can be endogenous from colonization of the microbe on the skin and in the gastrointestinal tract or exogenous as a result of the ubiquitous nature of the organism (Enterobacter Infections 2008). Most exogenous infections occur as a result of antibiotic treatments, venous catheter insertions or surgical procedures. Enterobacter aerogenes virulence is due to the lipopolysaccharides, lipid A, which acts as an endotoxin. The Lipid A acts as a stimulus for release of cytokines, mediators for systemic inflammation (Enterobacter Infections 2008). Treatment for Enterobacter aerogenes infections are usually with use of antimicrobial therapies. However, there is a rising concern with E. aerogenes developing drug resistance. E. aerogenes are generally resistant to narrow-spectrum penicillin drugs. They are also resistant to first and second generation cephalosporins. The response to third generation cephalosporins and extended spectrum penicillin varies. Fourth generation cephalosporins and carbapenems are fairly effective against E. aerogenes, however, resistance has been reported to those drugs as well.
F. SPECIAL CHARACTERISTICS
Enterobacter aerogenes is motile through peritrichous flagella. It can be differentiated from Enterobacter cloacae by lysine deaminase test. Early studies have shown that E. aerogenes is more closely related to Klebsiella than to E. cloacae, and there are current debates about reclassifying E. aerogenes. (Janda 2005). The microorganism is becoming increasingly more significant because of the rise in resistance of Enterobacter aerogenes infections to antibiotics and its association with nosocomial infections.
WORKS CITED
1. Bacillus subtilis Final Risk Assessment [internet]. [updated 2007 Sept. 24] U.S. Environmental Protection Agency, Biotechnology Program Under Toxic Substances Control Act (TSCA); [cited 2009 August 4]. Available from: http://www.epa.gov/biotech_rule/pubs/fra/fra009.htm 2. Bacteria Genomes Bacillus subtilis [internet]. [updated 2009]. European Bioinformatics Institute (EBI); [cited 2009 August 6]. Available from: http://www.ebi.ac.uk/2can/genomes/bacteria/Bacillus_subtilis.html. 3. Basic Characteristics for Identification of Selected Bacillus Species [internet]. [cited 2009 August 4]. Available from: http://faculty.sdmiramar.edu/dtrubovitz/micro/bacillus.pdf 4. Brown, Alfred. 2009. Bensons Microbiological Application Laboratory Manual in General Microbiology. Short version. 11th ed. McGraw Hill. p. 294. 5. Cappucchino, James G. and Natalie Sherman. 2001. Microbiology A Laboratory Manual. 6th ed. Benjamin Cummings. p. 428-431. 6. Differentiation of Enterobacteriaceae by Biochemical Test [internet]. [cited 2009 August 4]. Available from: http://faculty.sdmiramar.edu/dtrubovitz/micro/Enterobacteriaceae.pdf. 7. Differentiation of Typical Salmonella [internet]. [cited 2009 August 4]. Available from: http://faculty.sdmiramar.edu/dtrubovitz/micro/Salmonella.pdf. 8. Enterobacter Infections [internet]. [updated 2008 August 28]. EMedicine from WebMD; [cited 2009 August 6]. Available from: http://emedicine.medscape.com/article/216845-overview. 9. Janda, Michael J. and Sharon L. Abbot. 2005. The Enterobacteria [internet]. 2nd ed. ASM Press; [cited 2009 August 6]. Available from: http://books.google.com. 10. Microbial Glossary [internet]. Environmental Diagnostic Laboratory (EDL); [cited 2009 August 6]. Available from: http://www.pureaircontrols.com/glossary.html 11. Sonenshein, A.L., James A. Hoch, Richard Losick. 2002. Bacillus subtilis and its Closest Relatives [internet]. Washington DC: ASM Press American Society for Microbiology. [cited 2009 August 4]. Available from: http://books.google.com. 12. Stein, Torsten. 2005. Bacillus subtilis antibiotics: structures, synthesis and specific functions [internet]. Frankfurt, Germany: Institute fur Microbiologie. [cited 2009 August 6]. Available from: http://www3.interscience.wiley.com/journal/118659809/abstract?CRETRY=1&SRETRY=0.
10